Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 14,379 Less Arrow 2,450 More Arrow 3,751
Earnings before taxes -82,632 Less Arrow -111,035 Less Arrow -125,953
EBITDA -68,920 Less Arrow -111,297 Less Arrow -138,066
Total assets 145,330 Less Arrow 88,207 More Arrow 206,747
Current assets 86,338 Less Arrow 29,314 More Arrow 152,168
Current liabilities 63,916 Less Arrow 12,732 More Arrow 35,488
Equity capital 81,415 Less Arrow 75,297 More Arrow 171,077
- share capital 100,235 Less Arrow 35,325 Less Arrow 32,985
Employees (average) 11 More Arrow 23 Less Arrow 22

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 56.0% More Arrow 85.4% Less Arrow 82.7%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -47.0% Less Arrow -123.1% More Arrow -59.1%
Current ratio 135.1% More Arrow 230.2% More Arrow 428.8%
Return on equity (ROE) -101.5% Less Arrow -147.5% More Arrow -73.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -12 More Arrow 1 More Arrow 2
Chg. No. of employees % -52% More Arrow 5% More Arrow 10%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.